Aurora Cannabis Q4 2026 Earnings
As seen on the 24/7 Wall St. homepage on June 11, 2026.
Q4 2026
EPS
—
est $-0.14
—
Revenue
$85M
est $75M
+12.5%
Aurora Cannabis beat revenue estimates with $85M in quarterly sales, but warned fiscal 2027 results will slide back toward 2025 levels as Canadian medical reimbursement cuts effective April 1 wipe out gains from European expansion in Germany and Poland. International medical cannabis surged to nearly 91% of sales, yet the company's net loss widened to $27.6M and adjusted EBITDA contracted as margin pressure mounted.
ACB share price
Mentioned: ACB